Evaluating the Quality and Reliability of YouTube Videos on Optic Neuritis: A Cross-Sectional Study Using Validated Scoring Systems [0.03%]
使用验证过的评分系统对YouTube视频中关于视神经炎的质量和可靠性的横断面研究
Bedia Kesimal,Sıdıka Gerçeker Demircan,Sücattin İlker Kocamış
Bedia Kesimal
Background: YouTube is one of the largest internet platforms used worldwide. People often use this platform to get information. Since little is known about YouTube as a source of information on optic neuritis (ON), we inv...
Malak Habib
Malak Habib
Topical Dorzolamide for Macular Holes: A Randomised, Double-Blind, Placebo-Controlled Trial-Response [0.03%]
用于黄斑孔的局部布林佐胺：一项随机双盲假药对照试验--回应
Yong Min Lee,Bobak Bahrami,Robert J Casson et al.
Yong Min Lee et al.
Genotype-Phenotype Correlations in Corneal Dystrophies: Advances in Molecular Genetics and Therapeutic Insights [0.03%]
角膜营养不良的基因型-表型相关性：分子遗传学的进步和治疗见解
Petra Liskova,Pavlina Skalicka,Lubica Dudakova et al.
Petra Liskova et al.
Corneal dystrophies are a group of predominantly rare inherited disorders. They are by definition bilateral, relatively symmetrical, and without systemic involvement, affecting corneal transparency and/or refraction. Traditional classificat...
Rethinking Longitudinal Retinal Changes in Health and Disease: Response [0.03%]
健康与疾病状态下纵向视网膜变化的再思考：回应
Zhi Da Soh,Ching-Yu Cheng
Zhi Da Soh
Topical Dorzolamide for Macular Holes: A Randomised, Double-Blind, Placebo-Controlled Trial-Comment [0.03%]
治疗黄斑裂孔的局部应用Dorzolamide：一项随机双盲安慰剂对照试验-评论
Nicolas Abihaidar,Nacim Bouheraoua,Vincent Borderie et al.
Nicolas Abihaidar et al.
Evidence on the Use of Topical Ciclosporin for Ocular Surface Disease: A Systematic Review and Meta-Analysis [0.03%]
眼表疾病使用外用环孢素的证据：系统回顾和荟萃分析
Ngozi C Chidi-Egboka,Leo Fan,Maria Qureshi et al.
Ngozi C Chidi-Egboka et al.
Background: To identify evidence on the use of topical CsA for ocular surface diseases (OSD). Methods: A literature search was conducte...
Guanghao Qin
Guanghao Qin
Hanru Wang,Bobak Bahrami,Sonia Huang et al.
Hanru Wang et al.
Background: Intravitreal bevacizumab has been used off-label to treat multiple ocular conditions for almost two decades. Reference bevacizumab, Avastin, was discontinued in Australia in 2021. A bevacizumab biosimilar, MVA...
Jonathan E Moore,Richard N McNeely,Salissou Moutari
Jonathan E Moore
Modern cataract surgery continues to advance, yet intraocular lens (IOL) based surgery in the small adult eye remains challenging. Thorough preoperative assessment and surgical preparation optimise postoperative outcomes in these cases. Adv...